Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Correspondence

Importance of Clinically Significant Anti-M Antibody in Hematopoietic Stem Cell Transplantation

Authors: Suvro Sankha Datta, Sabita Basu

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Naturally occurring anti-M antibodies are mostly of the IgM class, however, an IgG component can also be present along with IgM. The IgM anti-M antibodies can be ignored if they are not reactive at 37 °C, but the patient should receive M antigen-negative red blood cells if the antibody is reactive at 37 °C or if it is of IgG class. Here we discuss a case of clinically significant naturally occurring anti-M antibody had both IgM and IgG components in a 3 years old child who was a hematopoietic stem cell donor for her 6 years old sister suffering from beta-thalassemia major. The specificity and immunoglobulin class of the antibody was confirmed by antibody screening at wide thermal range, dithiothreitol treatment of serum and reaction of serum with enzyme treated panel cells.
Literature
1.
go back to reference Wolff E, Johnson B (1933) Studien uber die untergruppen A1 and A2 mit besonderer berucksichtigung der paternitatsuntersuchungen. Dtsch Ztschr Gerichtl Med 22:65–85 Wolff E, Johnson B (1933) Studien uber die untergruppen A1 and A2 mit besonderer berucksichtigung der paternitatsuntersuchungen. Dtsch Ztschr Gerichtl Med 22:65–85
2.
go back to reference Daniels G, Bromilow I (2007) Essential guide to blood groups, 1st edn. Blackwell Publishing, Hoboken, p 52CrossRef Daniels G, Bromilow I (2007) Essential guide to blood groups, 1st edn. Blackwell Publishing, Hoboken, p 52CrossRef
3.
go back to reference Harmening DM (1998) Modern blood banking and transfusion practices, 3rd edn. Jaypee, New Delhi, pp 153–154 Harmening DM (1998) Modern blood banking and transfusion practices, 3rd edn. Jaypee, New Delhi, pp 153–154
4.
go back to reference Sancho JM, Pujol M, Fernandez F et al (1998) Delayed haemolytic transfusion reaction due to anti-M antibody. Br J Haematol 103(1):268–269CrossRefPubMed Sancho JM, Pujol M, Fernandez F et al (1998) Delayed haemolytic transfusion reaction due to anti-M antibody. Br J Haematol 103(1):268–269CrossRefPubMed
5.
go back to reference Arora S, Doda V, Maria A, Kotwal U, Goyal S (2015) Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins. Asian J Transfus Sci 9(1):98–101CrossRefPubMedPubMedCentral Arora S, Doda V, Maria A, Kotwal U, Goyal S (2015) Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins. Asian J Transfus Sci 9(1):98–101CrossRefPubMedPubMedCentral
6.
go back to reference Ishida A, Ohto H, Yasuda H et al (2015) Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol. (E-pub ahead of print) Ishida A, Ohto H, Yasuda H et al (2015) Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol. (E-pub ahead of print)
7.
go back to reference Fung KM (ed) (2014) Technical manual, 18th edn. AABB, Bethesda, p 343 Fung KM (ed) (2014) Technical manual, 18th edn. AABB, Bethesda, p 343
8.
go back to reference Alperin JB, Riglin H, Branch DR et al (1983) Anti-M causing delayed hemolytic transfusion reaction. Transfusion 23:322–324CrossRefPubMed Alperin JB, Riglin H, Branch DR et al (1983) Anti-M causing delayed hemolytic transfusion reaction. Transfusion 23:322–324CrossRefPubMed
9.
go back to reference Mollison PL, Engelfriet CP, Contreras M (1987) Blood transfusion in clinical medicine, 8th edn. Blackwell, Oxford, pp 383–393 Mollison PL, Engelfriet CP, Contreras M (1987) Blood transfusion in clinical medicine, 8th edn. Blackwell, Oxford, pp 383–393
10.
go back to reference Mathur A, Dontula S, Jagannathan L (2011) An unusual case of a potentially clinically significant anti-M antibody in a healthy male blood donor without any history of blood transfusion. Blood Transfus 9:339PubMedPubMedCentral Mathur A, Dontula S, Jagannathan L (2011) An unusual case of a potentially clinically significant anti-M antibody in a healthy male blood donor without any history of blood transfusion. Blood Transfus 9:339PubMedPubMedCentral
11.
go back to reference Das R, Dubey A, Agrawal P, Chaudhary RK (2014) Spectrum of anti-M: a report of three unusual cases. Blood Transfus 12(1):99–102PubMedPubMedCentral Das R, Dubey A, Agrawal P, Chaudhary RK (2014) Spectrum of anti-M: a report of three unusual cases. Blood Transfus 12(1):99–102PubMedPubMedCentral
Metadata
Title
Importance of Clinically Significant Anti-M Antibody in Hematopoietic Stem Cell Transplantation
Authors
Suvro Sankha Datta
Sabita Basu
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0566-6

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine